Physician profile
Daniel Plumeri
NPI 1447767983
$12,600.79
in general payments reported to CMS, 2019-2025
32 companies · $3,031 in 2025
The $3,031 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,614 · 2022: $1,238 · 2023: $928 · 2024: $5,789 · 2025: $3,031.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,142 · Food and Beverage: $3,505 · Travel and Lodging: $59.83 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,142.00 |
| Food and Beverage | $3,504.53 |
| Travel and Lodging | $59.83 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $7,073.94 | 2021-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Mannkind Corporation | $859.54 | 2021-2025 | Afrezza |
| Lilly USA, LLC | $689.50 | 2021-2025 | Mounjaro, Jardiance |
| Medtronic, INC. | $601.10 | 2021-2025 | Minimed 780g, Guardian Connect |
| Beta Bionics, INC. | $443.95 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Boehringer Ingelheim Pharmaceuticals, INC. | $442.18 | 2021-2024 | Jardiance |
| Insulet Corporation | $395.32 | 2021-2025 | Omnipod |
| Abbvie INC. | $388.88 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $220.54 | 2021-2024 | |
| Amgen INC. | $189.59 | 2021-2024 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $149.06 | 2022 | |
| Corcept Therapeutics | $124.17 | 2021-2025 | Korlym |
| Amneal Pharmaceuticals LLC | $112.99 | 2021-2025 | Unithroid |
| Abbott Laboratories | $103.68 | 2021-2025 | Freestyle Libre 3 |
| Recordati_rare_diseases_inc. | $94.25 | 2022-2024 | Signifor Lar, Isturisa |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $88.71 | 2021 | |
| Ibsa Pharma INC. | $84.62 | 2021-2025 | Licart, Tirosint, Flector |
| Bayer Healthcare Pharmaceuticals INC. | $81.18 | 2022-2024 | |
| Pfizer INC. | $57.45 | 2021 | |
| Xeris Pharmaceuticals, INC. | $55.72 | 2021-2022 | |
| Sequel Med Tech, LLC | $48.09 | 2025 | Twiist |
| Alexion Pharmaceuticals, INC. | $39.66 | 2023-2024 | Strensiq |
| Tandem Diabetes Care, INC. | $35.16 | 2021-2022 | |
| Soleno Therapeutics, INC. | $32.47 | 2025 | Vykat Xr |
| Neurocrine Biosciences, INC. | $31.12 | 2025 | |
| Cequr Corporation | $30.89 | 2023-2024 | Cequr Simplicity |
| Eusa Pharma (US) LLC | $24.65 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $23.93 | 2021 | |
| Novo Nordisk INC | $21.57 | 2024 | Sogroya |
| Clarus Therapeutics INC. | $20.11 | 2021 | |
| Antares Pharma, INC. | $19.14 | 2021 | |
| Chiesi USA, INC. | $17.63 | 2024 | Mycapssa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Plumeri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.